Publication | Closed Access

Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways

InflammationMetabolic SyndromePi3 K/akt/foxo1HepatologyNf-kappa B PathwaysMedicineLiver PhysiologyLipid PeroxidationPathologyHepatotoxicityLiver DiseaseAlcohol-related Liver DiseaseHepatology FibrosisFatty Liver DiseasePharmacologyCell BiologyOxidative StressHealth Sciences